Effects of ADORA2A gene variation and caffeine on prepulse inhibition: A multi-level risk model of anxiety

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 40, Issue 1, 2013, Pages 115-121

  Gajewska, Agnieszka ^a   Blumenthal, Terry D ^b   Winter, Bernward ^c   Herrmann, Martin J ^a   Conzelmann, Annette ^a   Mühlberger, Andreas ^a   Warrings, Bodo ^a   Jacob, Christian ^a   Arolt, Volker ^c   Reif, Andreas ^a   Zwanzger, Peter ^c   Pauli, Paul ^a   Deckert, Jürgen ^a   Domschke, Katharina ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b WAKE FOREST UNIVERSITY   (United States)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Adenosine receptor 2 A; Anxiety sensitivity; Caffeine; Prepulse inhibition; Startle

Indexed keywords

ADENOSINE A2A RECEPTOR; CAFFEINE; CAFFEINE CITRATE; PLACEBO;

ADORA2A GENE; ANXIETY; ARTICLE; CONTROLLED STUDY; EMOTION; FACILITATION; FEMALE; GENDER; GENE; GENETIC VARIABILITY; GENOTYPE; HABITUATION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; INFORMATION PROCESSING; MALE; NORMAL HUMAN; PREPULSE INHIBITION; PSYCHOLOGICAL MODEL; RISK ASSESSMENT; STARTLE REFLEX;

ADULT; ANXIETY; CAFFEINE; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; RECEPTOR, ADENOSINE A2A; SENSORY GATING; SEX FACTORS; STARTLE REACTION;

EID: 84867894687     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2012.08.008     Document Type: Article

References (69)

1. Aasen I., Kolli L., Kumari V. Sex effects in prepulse inhibition and facilitation of the acoustic startle response: implications for pharmacological and treatment studies. J Psychopharmacol 2005, 19:39-45.
2. Alpers A., Pauli P. Deutsche Übersetzung des Angstsensitivitäts-Index 2002, Universität Würzburg.
3. Alsene K., Deckert J., Sand P., de Wit H. Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 2003, 28:1694-1702.
4. Andrews S.E., Blumenthal T.D., Flaten M.A. Effects of caffeine and caffeine-associated stimuli on the human startle eyeblink reflex. Pharmacol Biochem Behav 1998, 59:39-44.
5. Bannbers E., Kask K., Wikstrom J., Sundstrom Poromaa I. Lower levels of prepulse inhibition in luteal phase cycling women in comparison with postmenopausal women. Psychoneuroendocrinology 2010, 35:422-429.
6. Bhattacharya S.K., Satyan K.S., Chakrabarti A. Anxiogenic action of caffeine: an experimental study in rats. J Psychopharmacol 1997, 11:219-224.
7. Blumenthal T.D., Cuthbert B.N., Filion D.L., Hackley S., Lipp O.V., van Boxtel A. Committee report: guidelines for human startle eyeblink electromyographic studies. Psychophysiology 2005, 42:1-15.
8. Botella P., Parra A. Coffee increases state anxiety in males but not in females. Hum Psychopharmacol 2003, 18:141-143.
9. Boulenger J.P., Uhde T.W., Wolff E.A., Post R.M. Increased sensitivity to caffeine in patients with panic disorders. Preliminary evidence. Arch Gen Psychiatry 1984, 41:1067-1071.
10. Braff D.L., Geyer M.A., Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 2001, 156:234-258.
11. Callaway E., Naghdi S. An information processing model for schizophrenia. Arch Gen Psychiatry 1982, 39:339-347.
12. Charney D.S., Heninger G.R., Jatlow P.I. Increased anxiogenic effects of caffeine in panic disorders. Arch Gen Psychiatry 1985, 42:233-243.
13. Childs E., Hohoff C., Deckert J., Xu K., Badner J., de Wit H. Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 2008, 33:2791-2800.
14. Clark D.M. A cognitive approach to panic. Behav Res Ther 1986, 24:461-470.
15. Conzelmann A., Pauli P., Mucha R.F., Jacob C.P., Gerdes A.B., Romanos J., et al. Early attentional deficits in an attention-to-prepulse paradigm in ADHD adults. J Abnorm Psychol 2010, 119:594-603.
16. Cornelis M.C., El-Sohemy A., Campos H. Genetic polymorphism of the adenosine A2A receptor is associated with habitual caffeine consumption. Am J Clin Nutr 2007, 86:240-244.
17. Crowe R.R., Noyes R., Pauls D.L., Slymen D. A family study of panic disorder. Arch Gen Psychiatry 1983, 40:1065-1069.
18. Deckert J., Nothen M.M., Franke P., Delmo C., Fritze J., Knapp M., et al. Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol Psychiatry 1998, 3:81-85.
19. Deckert J., Catalano M., Syagailo Y.V., Bosi M., Okladnova O., Di Bella D., et al. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 1999, 8:621-624.
20. Domschke K., Deckert J. Genetics of anxiety disorders status quo and quo vadis. Curr Pharm Des 2012.
21. Domschke K., Hohoff C., Jacob C., Maier W., Fritze J., Bandelow B., et al. Chromosome 4q31-34 panic disorder risk locus: association of neuropeptide Y Y5 receptor variants. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:510-516.
22. Domschke K., Ohrmann P., Braun M., Suslow T., Bauer J., Hohoff C., et al. Influence of the catechol-O-methyltransferase val158met genotype on amygdala and prefrontal cortex emotional processing in panic disorder. Psychiatry Res 2008, 163:13-20.
23. Domschke K., Stevens S., Pfleiderer B., Gerlach A.L. Interoceptive sensitivity in anxiety and anxiety disorders: an overview and integration of neurobiological findings. Clin Psychol Rev 2010, 30:1-11.
24. Domschke K., Gajewska A., Winter B., Herrmann M.J., Warrings B., Muhlberger A., et al. ADORA2A gene variation, caffeine, and emotional processing: a multi-level interaction on startle reflex. Neuropsychopharmacology 2012, 37:759-769.
25. Duley A.R., Hillman C.H., Coombes S., Janelle C.M. Sensorimotor gating and anxiety: prepulse inhibition following acute exercise. Int J Psychophysiol 2007, 64:157-164.
26. Filion D.L., Dawson M.E., Schell A.M. Modification of the acoustic startle-reflex eyeblink: a tool for investigating early and late attentional processes. Biol Psychol 1993, 35:185-200.
27. Fisher S., Guillet R. Neonatal caffeine alters passive avoidance retention in rats in an age- and gender-related manner. Brain Res Dev Brain Res 1997, 98:145-149.
28. Flaten M.A., Elden A. Caffeine and prepulse inhibition of the acoustic startle reflex. Psychopharmacology (Berl) 1999, 147:322-330.
29. Hamilton S.P., Slager S.L., De Leon A.B., Heiman G.A., Klein D.F., Hodge S.E., et al. Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder. Neuropsychopharmacology 2004, 29:558-565.
30. Hart P., Farrell G.C., Cooksley W.G., Powell L.W. Enhanced drug metabolism in cigarette smokers. Br Med J 1976, 2:147-149.
31. Hohoff C., Mullings E.L., Heatherley S.V., Freitag C.M., Neumann L.C., Domschke K., et al. Adenosine A(2A) receptor gene: evidence for association of risk variants with panic disorder and anxious personality. J Psychiatr Res 2010, 44:930-937.
32. Huang Z.L., Qu W.M., Eguchi N., Chen J.F., Schwarzschild M.A., Fredholm B.B., et al. Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine. Nat Neurosci 2005, 8:858-859.
33. Jang K.L., Stein M.B., Taylor S., Livesley W.J. Gender differences in the etiology of anxiety sensitivity: a twin study. J Gend Specif Med 1999, 2:39-44.
34. Jovanovic T., Szilagyi S., Chakravorty S., Fiallos A.M., Lewison B.J., Parwani A., et al. Menstrual cycle phase effects on prepulse inhibition of acoustic startle. Psychophysiology 2004, 41:401-406.
35. Kuhn S., Schubert F., Gallinat J. Structural correlates of trait anxiety: reduced thickness in medial orbitofrontal cortex accompanied by volume increase in nucleus accumbens. J Affect Disord 2011, 134:315-319.
36. Kumari V., Gray J.A. Smoking withdrawal, nicotine dependence and prepulse inhibition of the acoustic startle reflex. Psychopharmacology (Berl) 1999, 141:11-15.
37. Kumari V., Konstantinou J., Papadopoulos A., Aasen I., Poon L., Halari R., et al. Evidence for a role of progesterone in menstrual cycle-related variability in prepulse inhibition in healthy young women. Neuropsychopharmacology 2010, 35:929-937.
38. Lam P., Hong C.J., Tsai S.J. Association study of A2a adenosine receptor genetic polymorphism in panic disorder. Neurosci Lett 2005, 378:98-101.
39. Ludewig S., Ludewig K., Geyer M.A., Hell D., Vollenweider F.X. Prepulse inhibition deficits in patients with panic disorder. Depress Anxiety 2002, 15:55-60.
40. Ludewig S., Geyer M.A., Ramseier M., Vollenweider F.X., Rechsteiner E., Cattapan-Ludewig K. Information-processing deficits and cognitive dysfunction in panic disorder. J Psychiatry Neurosci 2005, 30:37-43.
41. McNally R.J. Anxiety sensitivity and panic disorder. Biol Psychiatry 2002, 52:938-946.
42. Mikalsen A., Bertelsen B., Flaten M.A. Effects of caffeine, caffeine-associated stimuli, and caffeine-related information on physiological and psychological arousal. Psychopharmacology (Berl) 2001, 157:373-380.
43. Muhlberger A., Wieser M.J., Pauli P. Darkness-enhanced startle responses in ecologically valid environments: a virtual tunnel driving experiment. Biol Psychol 2008, 77:47-52.
44. Nardi A.E., Valenca A.M., Nascimento I., Freire R.C., Veras A.B., de-Melo-Neto V.L., et al. A caffeine challenge test in panic disorder patients, their healthy first-degree relatives, and healthy controls. Depress Anxiety 2008, 25:847-853.
45. Nillni Y.I., Toufexis D.J., Rohan K.J. Anxiety sensitivity, the menstrual cycle, and panic disorder: a putative neuroendocrine and psychological interaction. Clin Psychol Rev 2011, 31:1183-1191.
46. Noschang C.G., Pettenuzzo L.F., von Pozzer Toigo E., Andreazza A.C., Krolow R., Fachin A., et al. Sex-specific differences on caffeine consumption and chronic stress-induced anxiety-like behavior and DNA breaks in the hippocampus. Pharmacol Biochem Behav 2009, 94:63-69.
47. Olatunji B.O., Deacon B.J., Abramowitz J.S., Valentiner D.P. Body vigilance in nonclinical and anxiety disorder samples: structure, correlates, and prediction of health concerns. Behav Ther 2007, 38:392-401.
48. Pauli P., Marquardt C., Hartl L., Nutzinger D.O., Holzl R., Strian F. Anxiety induced by cardiac perceptions in patients with panic attacks: a field study. Behav Res Ther 1991, 29:137-145.
49. Pauli P., Dengler W., Wiedemann G., Montoya P., Flor H., Birbaumer N., et al. Behavioral and neurophysiological evidence for altered processing of anxiety-related words in panic disorder. J Abnorm Psychol 1997, 106:213-220.
50. Pauli P., Amrhein C., Muhlberger A., Dengler W., Wiedemann G. Electrocortical evidence for an early abnormal processing of panic-related words in panic disorder patients. Int J Psychophysiol 2005, 57:33-41.
51. Pauli P., Amrhein C., Mühlberger A., Dengler W., Wiedemann G. Phenomenology of panic and phobic disorders. Oxford Handbook of Anxiety and Related Disorders 2008, 34-46. Oxford University Press, New York. M.M. Antony, M.B. Stein (Eds.).
52. Pauli P., Conzelmann A., Mucha R.F., Weyers P., Baehne C.G., Fallgatter A.J., et al. Affect-modulated startle reflex and dopamine D4 receptor gene variation. Psychophysiology 2010, 47:25-33.
53. Peterson R.A., Reiss S. Anxiety Sensitivity Index Manual 1992, Interantational Diagnostic Systems, Worthington, OH.
54. Postma P., Kumari V., Sharma T., Hines M., Gray J.A. Startle response during smoking and 24h after withdrawal predicts successful smoking cessation. Psychopharmacology (Berl) 2001, 156:360-367.
55. Renda G., Zimarino M., Antonucci I., Tatasciore A., Ruggieri B., Bucciarelli T., et al. Genetic determinants of blood pressure responses to caffeine drinking. Am J Clin Nutr 2012, 95:241-248.
56. Rogers P.J., Hohoff C., Heatherley S.V., Mullings E.L., Maxfield P.J., Evershed R.P., et al. Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine consumption. Neuropsychopharmacology 2010, 35:1973-1983.
57. Schicatano E.J., Blumenthal T.D. Caffeine delays habituation of the human acoustic startle reflex. Psychobiology 1994, 22:117-122.
58. Schicatano E.J., Blumenthal T.D. The effects of different doses of caffeine on habituation of the human acoustic startle reflex. Pharmacol Biochem Behav 1995, 52:231-236.
59. Schmidt N.B., Zvolensky M.J., Maner J.K. Anxiety sensitivity: prospective prediction of panic attacks and Axis I pathology. J Psychiatr Res 2006, 40:691-699.
60. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59(Suppl. 20):22-33. [quiz 34-57].
61. Swerdlow N.R., Auerbach P., Monroe S.M., Hartston H., Geyer M.A., Braff D.L. Men are more inhibited than women by weak prepulses. Biol Psychiatry 1993, 34:253-260.
62. Swerdlow N.R., Hartman P.L., Auerbach P.P. Changes in sensorimotor inhibition across the menstrual cycle: implications for neuropsychiatric disorders. Biol Psychiatry 1997, 41:452-460.
63. Swerdlow N.R., Eastvold A., Gerbranda T., Uyan K.M., Hartman P., Doan Q., et al. Effects of caffeine on sensorimotor gating of the startle reflex in normal control subjects: impact of caffeine intake and withdrawal. Psychopharmacology (Berl) 2000, 151:368-378.
64. Swerdlow N.R., Geyer M.A., Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl) 2001, 156:194-215.
65. Toufexis D.J., Myers K.M., Davis M. The effect of gonadal hormones and gender on anxiety and emotional learning. Horm Behav 2006, 50:539-549.
66. Vieland V.J., Goodman D.W., Chapman T., Fyer A.J. New segregation analysis of panic disorder. Am J Med Genet 1996, 67:147-153.
67. Weissman M.M., Bland R.C., Canino G.J., Faravelli C., Greenwald S., Hwu H.G., et al. The cross-national epidemiology of panic disorder. Arch Gen Psychiatry 1997, 54:305-309.
68. Weissman M.M., Fyer A.J., Haghighi F., Heiman G., Deng Z., Hen R., et al. Potential panic disorder syndrome: clinical and genetic linkage evidence. Am J Med Genet 2000, 96:24-35.
69. Yamada K., Hattori E., Shimizu M., Sugaya A., Shibuya H., Yoshikawa T. Association studies of the cholecystokinin B receptor and A2a adenosine receptor genes in panic disorder. J Neural Transm 2001, 108:837-848.